文献速递腹部泌尿生殖US

对比增强超声(CEUS):从肾脏到膀胱的应用

Contrast-enhanced ultrasound (CEUS): applications from the kidneys to the bladder.
PubMed 文献 · Abdom Radiol (NY) · 2024-06-17

本文为综述,阐述对比增强超声(CEUS)利用超声造影剂显示解剖与血管结构及微循环,在泌尿系统从肾脏到膀胱的多病种应用。EFSUMB 2018 更新指南描述了 CEUS 在非肝脏应用的使用。CEUS 安全性好、空间分辨率高,部分情况下可与增强 CT 媲美甚至更优,但膀胱癌定量分期及肾良恶性肿块鉴别仍需进一步研究。

要点

  • CEUS 可评估复杂囊性肾病变、不确定病变、假肿瘤与实性肾肿瘤鉴别、肾感染及肾缺血性疾病。
  • 常规超声结果不明确时,CEUS 对鉴别膀胱血肿与膀胱癌极有用。
  • CEUS 时间-强度曲线定量参数已用于膀胱癌分期分级研究,但确定性分期仍需进一步研究。

核心结论

  • CEUS 是评估泌尿系统多种病变的安全、准确、经济、易得且快速的检查手段,部分情况下可与增强 CT 媲美甚至更优。
  • CEUS 在肾囊性病变分类方面非常有效,但鉴别肾良恶性肿块仍需进一步研究。
  • 利用定量 CEUS 对膀胱癌进行确定性分期并区分肌层浸润与非肌层浸润以指导适当干预,仍需进一步研究。

研究设计与样本

  • 本文为综合性综述,聚焦 CEUS 在从肾脏到膀胱的泌尿系统评估中的应用。
  • 引用欧洲超声医学与生物学联合会(EFSUMB)2018 年更新的非肝脏应用指南。
  • 原文未报告系统检索范围与纳入文献数量。

关键影像表现/征象

  • CEUS 利用超声造影剂显示解剖与血管结构,包括微循环的显示。
  • 在膀胱,常规超声结果不明确时,CEUS 极有助于鉴别膀胱血肿与膀胱癌。
  • CEUS 时间-强度曲线(TIC)的定量参数已被研究用于膀胱癌的分期和分级。

诊断标准与关键数值

  • 原文未报告敏感度、特异度、AUC、阈值或分级标准的具体数值。

临床应用与阅片要点

  • CEUS 可用于评估复杂囊性肾病变、不确定病变、假肿瘤与实性肾肿瘤的鉴别、肾感染及肾缺血性疾病。
  • CEUS 也已用于评估肾移植。
  • 常规超声对膀胱血肿与膀胱癌鉴别不明确时,CEUS 极有用。
  • CEUS 因使用非肾毒性超声造影剂而安全,成本低于 CT 或 MRI,可能减轻需长期随访患者的经济负担。

局限性

  • 利用定量 CEUS 对膀胱癌进行确定性分期并区分肌层浸润与非肌层浸润,仍需进一步研究。
  • 鉴别肾良恶性肿块仍需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Contrast-enhanced ultrasound (CEUS) is an advanced ultrasound (US) technique utilizing ultrasound contrast agents (UCAs) to provide detailed visualization of anatomic and vascular architecture, including the depiction of microcirculation. CEUS has been well-established in echocardiography and imaging of focal hepatic lesions and recent studies have also shown the utility of CEUS in non-hepatic applications like the urinary system. The updated guidelines by the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) from 2018 describe the use of CEUS for non-hepatic applications. CEUS' excellent safety profile and spatial resolution make it a superior modality to conventional US and is often comparable and even superior to CECT in some instances. In comparison to other cross-sectional imaging modalities such as CECT or MRI, CEUS offers a safe (by virtue of non-nephrotoxic US contrast agents), accurate, cost-efficient, readily available, and a quick means of evaluation of multiple pathologies of the urinary system. CEUS also has the potential to reduce the overall economic burden on patients requiring long-term follow-up due to its low cost as compared to CT or MRI techniques. This comprehensive review focuses on the applications of CEUS in evaluating the urinary system from the kidneys to the urinary bladder. CEUS can be utilized in the kidney to evaluate complex cystic lesions, indeterminate lesions, pseudotumors (vs solid renal tumors), renal infections, and renal ischemic disorders. Additionally, CEUS has also been utilized in evaluating renal transplants. In the urinary bladder, CEUS is extremely useful in differentiating a bladder hematoma and bladder cancer when conventional US techniques show equivocal results. Quantitative parameters of time-intensity curves (TICs) of CEUS examinations have also been studied to stage and grade bladder cancers. Although promising, further research is needed to definitively stage bladder cancers and classify them as muscle-invasive or non-muscle invasive using quantitative CEUS to guide appropriate intervention. CEUS has been very effective in the classification of cystic renal lesions, however, further research is needed in differentiating benign from malignant renal masses.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Srivastava S, Dhyani M, Dighe M, et al. Contrast-enhanced ultrasound (CEUS): applications from the kidneys to the bladder. Abdom Radiol (NY). 2024. PMID: 38884782. doi:10.1007/s00261-024-04388-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。